United States

Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal Cancers

TNX-1700 is Under Development as Monotherapy and in Combination with Anti-PD1 Checkpoint Inhibitor Therapy in Animal Models of Two Challenging Cancers In Mouse Models, rTFF2 Detoxifies the Tumor Microenvironment, Allows Activation of Cancer-Killing CD8+T Cells…

Read More »

Embark Trucks to Participate in Upcoming Investor Conferences

Xos Announces Partnership with Merchants Fleet to Grow EV Portfolio for Last Mile Delivery

Agios Announces Data from Investigator-led Studies of Mitapivat in Adults with Sickle Cell Disease Demonstrating Improvements in Anemia, Hemolysis and Sickling Parameters at 63rd ASH Annual Meeting and Exposition

Imara Presents Clinical and Preclinical Tovinontrine (IMR-687) Data at the American Society of Hematology (ASH) Annual Meeting 2021

OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)

Gritstone bio Added to the Nasdaq Biotechnology Index

Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients

TransUnion Announces Partnership with HomeFree-USA to Help Close Racial Homeownership Gap

Paramount Gold Announces the Voting Results of Its 2021 Annual General Meeting

First Wave BioPharma Chairman and CEO Issues Letter to Shareholders

Reliance Steel & Aluminum Co. Acquires Nu-Tech Precision Metals Inc.

Athenex to Host a KOL Webinar Today on CAR-NKT Cell Approach to Cancer and Latest Data at the 63rd ASH Annual Meeting

Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting

Aterian And Recurrent Announce A Strategic Online Media and E-Commerce Partnership

Coherus and Junshi Biosciences Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax

Ocean Power Technologies Appoints Robert Powers as New CFO

Brown & Brown, Inc. announces the asset acquisition of Corporate Insurance Advisors, L.L.C.